FREE Account Opening + No Clearing Fees
Loading...

Mankind Pharma IPO vs Nexus Select Trust REIT

Comparision between Mankind Pharma IPO and Nexus Select Trust REIT.

Issue Size and Price

The total issue size of Mankind Pharma IPO is up to ₹4,326.36 Cr whereas the issue size of the Nexus Select Trust REIT is up to ₹3,200.00 Cr. The final issue price of Mankind Pharma IPO is ₹1,080.00 per share and of Nexus Select Trust REIT is ₹100.00 per share.

  Mankind Pharma IPO Nexus Select Trust REIT
Face Value ₹1 per share
Issue Price (Lower) ₹1,026.00 per share ₹95.00 per share
Issue Price (Upper) ₹1,080.00 per share ₹100.00 per share
Issue Price (Final) ₹1,080.00 per share ₹100.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 13 shares 150 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹1,400.00 Cr
OFS Issue Size 4,00,58,844 shares
OFS Issue Size (Amount) up to ₹4,326.36 Cr up to ₹1,800.00 Cr
Issue Size Total 4,00,58,844 shares
Issue Size Total (Amount) up to ₹4,326.36 Cr up to ₹3,200.00 Cr

IPO Timetable

Mankind Pharma IPO opens on Apr 25, 2023, while Nexus Select Trust REIT opens on May 09, 2023. The closing date of Mankind Pharma IPO and Nexus Select Trust REIT is Apr 27, 2023, and May 11, 2023, respectively.

  Mankind Pharma IPO Nexus Select Trust REIT
Anchor Bid Date Apr 24, 2023 May 08, 2023
Issue Open Apr 25, 2023 May 09, 2023
Issue Close Apr 27, 2023 May 11, 2023
Basis Of Allotment (Tentative) May 03, 2023 May 16, 2023
Initiation of Refunds (Tentative) May 04, 2023 May 17, 2023
Credit of Share (Tentative) May 05, 2023 May 18, 2023
Listing date (Tentative) May 09, 2023 May 19, 2023
Anchor Lockin End date 1 Jun 02, 2023 Jun 15, 2023
Anchor Lockin End date 2 Aug 01, 2023 Aug 14, 2023

Financials

Mankind Pharma IPO P/E ratio is 32.5, as compared to Nexus Select Trust REIT P/E ratio of .

  Mankind Pharma IPO Nexus Select Trust REIT
Financial
Mankind Pharma Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-205,073.295,975.651,056.153,485.313,436.34126.92
31-Mar-216,372.636,385.381,293.034,722.004,674.39234.53
31-Dec-218,043.886,218.291,260.245,965.465,916.86268.70
31-Mar-229,147.747,977.581,452.966,155.236,106.06868.03
31-Dec-229,273.756,777.821,015.987,145.897,094.12167.93
Amount in ₹ Crore
Nexus Select Trust Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxReserves and SurplusTotal Borrowing
31-Mar-209,527.641,708.19206.74976.055,955.67
31-Mar-218,959.361,047.97-199.11340.896,281.38
31-Mar-229,089.771,398.52-10.95389.156,311.20
31-Dec-228,989.531,498.35257.02639.315,872.31
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 79.00%
Promoter Shareholding (Post-Issue) 76.50%
P/E Ratio 32.5
Market Cap ₹43263.60 Cr.
ROE 27.60%%
ROCE 26.10%%
Debt/Equity
EPS ₹33.20
RoNW 27.70%%

Shares Offered

In the Mankind Pharma IPO retail investors (RII) are offered 1,40,20,596 shares while in Nexus Select Trust REIT retail investors are offered 1,40,20,596 shares. Qualified institutional buyers (QIB) are offered 80,11,769 shares in Mankind Pharma IPO and 10,10,52,450 shares in Nexus Select Trust REIT.

  Mankind Pharma IPO Nexus Select Trust REIT
Anchor Investor Reserveration 1,20,17,652 shares 14,39,99,850 shares
Market Maker Reserveration
QIB 80,11,769 shares 10,10,52,450 shares
NII 60,08,827 shares 0 shares
RII 1,40,20,596 shares 0 shares
Employee 0 shares 0 shares
Others
Total 2,80,41,192 shares 18,52,63,050 shares

Bids Received (Subscription)

Mankind Pharma IPO subscribed 15.32x in total, whereas Nexus Select Trust REIT subscribed 5.45x.

  Mankind Pharma IPO Nexus Select Trust REIT
QIB (times) 49.16x 4.81x
NII (times) 3.80x
Big NII (times) 4.99x
Small NII (times) 1.41x
RII (times) 0.92x
Employee (times)
Other (times) 6.23x
Total (times) 15.32x 5.45x

Comments

Add a public comment...